Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 456 is classified as a *pseudogene*, meaning it is a non-functional copy of a gene related to the 5S ribosomal RNA gene family[1]. Pseudogenes arise from gene duplication or retrotransposition events and typically do not code for functional RNAs or proteins due to disabling mutations or lack of regulatory elements[2][6]. The functional 5S ribosomal RNA is an approximately 120-nucleotide molecule that is a structural component of the large ribosomal subunit involved in protein synthesis, but pseudogenes such as RNA5SP456 are generally considered “dead” copies and do not contribute directly to ribosome function[3][1]. Recent advances show some pseudogenes may be transcribed and compete for RNA-binding proteins, sometimes affecting the regulation of their parental gene, but such functions require experimental validation for each pseudogene and are rare exceptions[2]. No direct evidence supports an active biological or disease-related role for RNA5SP456.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 456 (RNA5SP456).